Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer.
FDG-PET
anal cancer
metabolic tumour volume
prognosis
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
09 Jun 2020
09 Jun 2020
Historique:
received:
27
03
2020
revised:
29
05
2020
accepted:
06
06
2020
entrez:
13
6
2020
pubmed:
13
6
2020
medline:
13
6
2020
Statut:
epublish
Résumé
Due to the heterogeneity of tumour mass segmentation methods and lack of consensus, our study evaluated the prognostic value of pretherapeutic positron emission tomography with fluorodeoxyglucose (FDG-PET) metabolic parameters using different segmentation methods in patients with localized anal squamous cell carcinoma (SCC). Eighty-one patients with FDG-PET before radiochemotherapy were retrospectively analyzed. Semiquantitative data were measured with three fixed thresholds (35%, 41% and 50% of Maximum Standardized Uptake Value (SUVmax)) and four segmentation methods based on iterative approaches (Black, Adaptive, Nestle and Fitting). Metabolic volumes of primary anal tumour (P-MTV) and total tumour load (T-MTV: P-MTV+ lymph node MTV) were calculated. The primary endpoint was event-free survival (EFS). Seven multivariate models were created to compare FDG-PET tumour volumes prognostic impact. For all segmentation thresholds, PET metabolic volume parameters were independent prognostic factor and T-MTV variable was consistently better associated with EFS than P-MTV. Patient's sex was an independent variable and significantly correlated with EFS. With fixed threshold segmentation methods, 35% of SUVmax threshold seemed better correlated with EFS and the best cut-off for discrimination between a low and high risk of event occurrence was 40 cm
Identifiants
pubmed: 32527039
pii: cancers12061512
doi: 10.3390/cancers12061512
pmc: PMC7352672
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
N Engl J Med. 2000 Mar 16;342(11):792-800
pubmed: 10717015
Radiother Oncol. 2008 Jun;87(3):376-82
pubmed: 18453023
Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):638-45
pubmed: 24035327
Cancer. 1983 May 15;51(10):1830-7
pubmed: 6831349
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):134-41
pubmed: 22000745
J Natl Compr Canc Netw. 2012 Apr;10(4):449-54
pubmed: 22491045
Radiol Med. 2016 Jan;121(1):54-9
pubmed: 26126968
Phys Med Biol. 2009 Nov 21;54(22):6901-16
pubmed: 19864698
J Nucl Med. 2005 Aug;46(8):1342-8
pubmed: 16085592
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):66-72
pubmed: 22592047
Phys Med Biol. 2012 Sep 7;57(17):5381-97
pubmed: 22864012
Int J Colorectal Dis. 2011 Feb;26(2):201-10
pubmed: 21061012
Hematol Oncol Clin North Am. 2012 Dec;26(6):1315-50
pubmed: 23116582
Int J Radiat Oncol Biol Phys. 1994 Apr 30;29(1):17-23
pubmed: 8175426
Br J Radiol. 2019 May;92(1097):20181006
pubmed: 30810343
Eur J Nucl Med Mol Imaging. 2017 Jan;44(1):63-70
pubmed: 27503193
Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1272-82
pubmed: 15519800
Int J Radiat Oncol Biol Phys. 1989 Dec;17(6):1141-51
pubmed: 2599902
Radiother Oncol. 2010 Jun;95(3):288-91
pubmed: 20231040
Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):720-5
pubmed: 16626889
Eur J Radiol. 2016 Aug;85(8):1390-4
pubmed: 27423677
Lancet. 1996 Oct 19;348(9034):1049-54
pubmed: 8874455
Br J Radiol. 2017 Dec;90(1080):20170370
pubmed: 28972796
Ann Surg Oncol. 2015 Oct;22(11):3574-81
pubmed: 25652048
Ann Oncol. 2014 Sep;25 Suppl 3:iii10-20
pubmed: 25001200
Dig Liver Dis. 2017 Aug;49(8):831-840
pubmed: 28610905
Ann Oncol. 2012 Aug;23(8):2078-2082
pubmed: 22294527
Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2790-2799
pubmed: 31482428
Dis Colon Rectum. 1987 May;30(5):324-33
pubmed: 3568920
J Nucl Med. 2013 Jan;54(1):27-32
pubmed: 23236018
Br J Cancer. 2009 Mar 10;100(5):693-700
pubmed: 19259091
Radiother Oncol. 2010 Sep;96(3):302-7
pubmed: 20708286
Contrast Media Mol Imaging. 2018 Dec 4;2018:9760492
pubmed: 30627062
Cancer. 2013 Feb 15;119(4):748-55
pubmed: 23011911
JAMA. 2008 Apr 23;299(16):1914-21
pubmed: 18430910
Cancer Radiother. 2010 Nov;14 Suppl 1:S120-6
pubmed: 21129654
J Clin Oncol. 1997 May;15(5):2040-9
pubmed: 9164216
Eur J Nucl Med Mol Imaging. 2012 Nov;39(11):1670-2
pubmed: 22968400
Am J Surg. 1984 Jan;147(1):43-8
pubmed: 6691550
Cancer. 2010 Sep 1;116(17):4007-13
pubmed: 20564111
Cancer. 1997 Dec 15;80(12 Suppl):2505-9
pubmed: 9406703
Radiother Oncol. 2019 Jul;136:21-28
pubmed: 31015125
Br J Cancer. 2011 Aug 9;105(4):498-504
pubmed: 21792197